Thomas Charles Heineman insider trades

Open-market stock purchases and sales by Thomas Charles Heineman, Chief Medical Officer at Oncolytics Biotech Inc, from SEC Form 4 filings since Feb 12, 2026.

Recent trades

DateStockTradeValue
Jun 1, 2026ONCY Oncolytics Biotech IncBought (not open market)—
Feb 12, 2026ONCY Oncolytics Biotech IncBought$10K

Companies traded

  • ONCY Oncolytics Biotech Inc: 1 buy, last Jun 1, 2026

Get free alerts when Thomas Charles Heineman files a new trade →